Abingworth Appoints Dr Shelley Chu as Partner

Abingworth, the international investment group dedicated to life sciences, today announced that Shelley Chu, MD, PhD has joined Abingworth as a Partner. Shelley, who brings more than 20 years of experience in venture capital, business d

Inside Trade: Michael Dougherty Paid for 2000 Shares of Cempra Inc (NASDAQ ...

Abingworth Llp revealed it had acquired a stake worth 6.69 of the fund

Vertex Steps Into Gene Editing With CRISPR Tx Collab

Vertex joins as an equity holder GlaxoSmithKline